Form 4 for AORT ARTIVION, INC.
Accepted 2025-11-14 00:00:00 ET · period of report 2025-11-13 · accession 0001628280-25-052260 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-14 | 2025-11-13 | AORT | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $45.86 | -4,993 | 56.6K | -8% | -$229.0K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-13 | S | D | 4,993 | $45.86 | 56,641 | D | — | — | (F1) These shares were sold upon the vesting of restricted stock units to pay tax withholding obligations. The sale was to satisfy tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary transaction. |